Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study-Reference-Cited by-同舟云学术

Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study

Published:2000-10 Issue:2 Volume:152 Page:489-496
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Aguilar-Salinas Carlos A.,Gómez-Pérez Francisco J.,Posadas-Romero Carlos,Vázquez-Chávez Cuauhtémoc,Meaney Eduardo,Gulı́as-Herrero Alfonso,Guillén Luz E.,Alvarado Vega Alma,Mendoza Pérez Enrique,Eduardo Romero-Nava Luis,Angélica Gómez-Dı́az Rita,Salinas-Orozco Saúl,Moguel Rafael,Novoa Germán

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Effects of gemfibrozil on triglyceride levels in patients with NIDDM;Vinik;Diab. Care,1993

2. Lipoprotein abnormalities in well-treated Type II diabetic patients;Manzato;Diab. Care,1993

3. American Diabetes Association. Clinical Practice Recommendations 1998. Diabetes Care 1998;21 (Suppl 1) 179–182.

4. Consensus Statement. Detection and management of lipid disorders in diabetes. Diab. Care 1993;16 (2):106–112.

5. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia;Raskin;Am. J. Med.,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid quantitation of atorvastatin in process pharmaceutical powder sample using Raman spectroscopy and evaluation of parameters related to accuracy of analysis;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2018-07

2. The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia;Tzu Chi Medical Journal;2013-09

3. Lipid lowering efficacy of atorvastatin;Cochrane Database of Systematic Reviews;2012-12-12

4. Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy;Clinical Biochemistry;2011-02

5. Response: A Retrospective Study on the Efficacy of a Ten-Milligram Dosage of Atorvastatin for Treatment of Hypercholesterolemia in Type 2 Diabetes Mellitus Patients (Korean Diabetes J 2010;34:359-67);Diabetes & Metabolism Journal;2011